Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
about
Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsClinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cellshiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesDeveloping stem cell therapies for juvenile and adult-onset Huntington's diseaseBone Physiology, Biomaterial and the Effect of Mechanical/Physical Microenvironment on MSC Osteogenesis: A Tribute to Shu Chien's 80th BirthdayA modified aggregate culture for chondrogenesis of human adipose-derived stem cells genetically modified with growth and differentiation factor 5In vitro evaluation of cell-seeded chitosan films for peripheral nerve tissue engineering.Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.Enhanced hepatogenic transdifferentiation of human adipose tissue mesenchymal stem cells by gene engineering with Oct4 and Sox2.Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs).Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy.Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseLong-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injuryTransient exposure to TGF-β3 improves the functional chondrogenesis of MSC-laden hyaluronic acid hydrogelsRegulation of Immunity via Multipotent Mesenchymal Stromal Cells.Upregulation of Adipogenesis and Chondrogenesis in MSC Serum-Free Culture.Neurogenic potential of engineered mesenchymal stem cells overexpressing VEGFConcise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectivesHuman Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products.Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapyTendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?Stem cell therapy: from bench to bedside.Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?Realizing the potential of gene-based molecular therapies in bone repair.Perspectives on the use of stem cells for autism treatmentWould cancer stem cells affect the future investment in stem cell therapy.Mesenchymal stem cells in treating autism: Novel insights.Mesenchymal stem cells as a potential therapeutic tool for spinocerebellar ataxia.Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process.CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells.Engineered BDNF producing cells as a potential treatment for neurologic disease.Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases.
P2860
Q21285056-E68FA50C-3EB2-42DF-BC25-7080E2C98BF4Q26741260-8A6E3867-E1E3-4F7D-86D4-5E94119BF9CAQ26747603-D7D26C1B-66DD-49C3-B819-ACBA4AD12FDEQ26751506-D313BB98-0C20-47B1-BD2B-3117FF775802Q26799013-AAE8B452-3BDA-40C3-8F1B-1BC77AE44447Q26799722-D7316299-387B-435A-9620-6AAD3F3D5DF5Q28652480-8041E750-B500-44B0-ACEE-371CCAB94CA6Q30417785-8ECE7E71-0135-4D48-AFE7-F19F7F1901D4Q34164208-23750F20-1A52-4D9C-AD4B-527757008CF1Q34482943-1462DE8B-54EB-4803-895B-6C065F51BE7BQ34509669-58F4D188-12FB-4994-BA6A-9B70250C3E6AQ35091885-13C6A576-D20B-4B26-8D30-4621366183AFQ35224958-8A67BF99-AC37-4843-B887-0493ED7A1041Q35395603-034E0B51-377B-4E6D-9C04-3006D2A67373Q35590505-375AC8A7-4110-4920-970E-C985C879CAF3Q35675598-E4FBCEB4-E495-4183-A8C1-7FB61FBCE153Q35865475-4EDF210E-1042-4E2E-93E0-FCDD589AE1CAQ36008330-91F191CB-567B-4408-9C9D-5EFECE0CB1C2Q36025982-05ED1C28-F98B-47D8-9669-6136F8303B08Q36680590-97F26539-4AE0-47BF-AC56-0DD9AC2ADDCBQ36795036-0BFDCE40-D1BD-4EB7-B167-1C9CB28C5992Q36862085-EC3997FF-5FCF-4972-8213-293B4730EC81Q36939755-B340E3D9-A792-4273-AB69-BFA7EAAD2AEFQ37016591-9F1FB319-D048-44D9-9E49-7357C0D57BFFQ37200221-06D0A8E6-82E3-416B-91D0-DE0039AFA02DQ37200224-164A2A3F-0DA6-4C48-8255-B78B577836C0Q37200247-D67CAE31-8658-4EE7-B8EF-62EEE1750837Q38042089-06B383B5-0E2D-4973-8971-1CCC6597E277Q38042584-235BCA7F-E8A7-437C-BF77-5A411BC117CAQ38062875-B34BCC8D-D3A5-4D7F-85FC-6D4AE9BE58CCQ38086083-7B392AA8-6F3A-4EC3-A9B4-2CDC7E4BC64AQ38095878-F5180C8D-CEA0-45B6-8B5D-808665408DD6Q38162181-666DEA27-6EB5-4BBD-B1B8-C79D3BA4BF8EQ38187419-C70E07E3-3961-47EB-9428-EFB3A2406598Q38207602-3158E6B2-15A9-4D99-848B-CB4ED7E1E561Q38256491-E218A679-68DB-4122-AE1A-E51E99E6D723Q38295640-45ED47A8-571E-47E3-86EC-1B577ADE3D7FQ38607206-7931A1DE-BF50-47DA-BD3D-D8412B3E3324Q38829577-5DB2724C-F8D0-4FC3-BE45-74E2A22563EBQ38897803-3A4B0F42-7005-49BC-9760-BCFF6B09BFBB
P2860
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@en
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@nl
type
label
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@en
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@nl
prefLabel
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@en
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
@nl
P2093
P2860
P1476
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors
@en
P2093
Geralyn Annett
Gerhard Bauer
Scott Olson
Stefanos Kalomoiris
Suzanne Pontow
Todd Meyerrose
Yunjoon Jung
P2860
P304
P356
10.1016/J.ADDR.2010.09.013
P407
P50
P577
2010-09-01T00:00:00Z